Delivery Order SPE2DB22D2206-SPE2DB24FEZ70
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Bromfenac Sodium 0.09% eye drops. This $1,488.72 contract has a performance period through March 21, 2024 and does not have a set-aside designation. Amerisourcebergen Drug Corp holds an indefinite delivery contract with DLA valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for...
- This $38,872.30 firm fixed-price delivery order contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of 4,562,911,110 units of Bromfenac Sodium 0.09% Eye Drops, 1.7 ml, to be delivered by November 28, 2023. No set-aside designation was used for this award. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,846.68 firm fixed-price delivery order is for the supply of Bromfenac Sodium 0.09% eye drops, with a performance period ending on May 8, 2024. The contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
- This federal contract award is for the delivery of Bromfenac Sodium 0.09% eye drops, valued at $3,445.49, awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract has an ultimate completion date of January 22, 2025 and is a firm fixed-price delivery order. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
- This $5,687.78 delivery order contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the procurement of Bromfenac Sodium 0.09% eye drops. The contract has a firm fixed price pricing type and an ultimate completion date of January 8, 2025. This award is associated with a broader Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The $5,626.85 firm fixed price delivery order is for the supply of Bromfenac Sodium 0.09% eye drops, with a completion date of March 15, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division located in Conshohocken, Pennsylvania, serves as a prime contractor...
- This federal contract award, valued at $2,720.55, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Bromfenac Sodium 0.09% eye drops, a prescription ophthalmic medication, with a completion date of May 17, 2023. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which is...
- The Defense Logistics Agency (DLA) awarded a $3,496.61 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a pharmaceutical distribution subsidiary of Cencora, Inc. The contract is for the supply of Bromsite 0.075% eye drops, a specialty medication. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, which enables the company to provide a comprehensive range of pharmaceutical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the delivery of Bromfenac Sodium 0.09% eye drops. The contract, valued at $1,138.02, is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a potential value of up to $999,999,999 through December 2025. This IDC allows the DLA to efficiently procure a comprehensive range of pharmaceutical and medical supplies from...
- This federal contract award, valued at $1,517.70, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Bromfenac Sodium 0.09% eye drops, a medication used to treat eye inflammation. The contract is a delivery order that falls under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by Amerisourcebergen with the DLA Troop Support Medical. This IDC serves as a primary vehicle...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB24FEZ70Delivery Order
The U.S. Defense Logistics Agency (DLA) awarded a $2,383.81 firm fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Bromfenac Sodium 0.09% eye drops. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen's extensive experience and capabilities in distributing a broad spectrum of medical commodities to federal agencies, including the DLA and the Department of Justice Federal Bureau of Investigation, make the company a key vendor for these critical government healthcare requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.4k | 1/9/24 |